Can we leverage immunotherapy against Alzheimer’s disease?
Currently, about 32 million people around the world live with Alzheimer's disease, the most common form of dementia.
With a growing aging population, experts expect dementia cases to spike to 152 million by 2050.Right now, there is no cure for Alzheimer’s disease, and medication options are lim
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article